Yoshida-Tanaka, Kugui
Shimada, Mihoko
Honda, Yoshiko
Fujimoto, Akihiro
Tokunaga, Katsushi
Honda, Makoto
Miyagawa, Taku
Funding for this research was provided by:
the Ministry of Education, Culture, Sports, Science and Technology of Japan (18K15053)
the Ministry of Education, Culture, Sports, Science and Technology of Japan (15H04709)
Japan Agency for Medical Research and Development
Article History
Received: 10 March 2023
Accepted: 22 June 2023
First Online: 28 June 2023
Competing interests
: Dr. Honda has received consultant fees from Takeda Pharmaceutical Company, Alfresa Pharma Corporation, Aculys Pharma Inc., and Ono Pharmaceutical Company for work completely unrelated to this research. None of the other authors have any financial conflicts of interest to disclose.